Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Act on Pharmacist's Recommendations for PRN Lorazepam Orders

Ivins, Utah Survey Completed on 05-20-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that irregularities identified by the pharmacist during the monthly drug regimen review were acted upon by the attending physician for one resident. Specifically, the pharmacist noted that the resident had a PRN order for Lorazepam that exceeded 14 days without a documented stop date or a rationale for extending the use or duration of treatment. Despite the pharmacist's recommendation to add a stop date and, if necessary, document the indication, intended duration, and rationale for continued use, there was no evidence in the resident's medical record that these requirements were met. The resident involved had multiple diagnoses, including palliative care, vascular dementia, cognitive communication deficit, anxiety disorder, post-traumatic stress disorder, and major depressive disorder. Multiple Lorazepam orders were initiated and discontinued over several months, with at least one order lacking the required documentation for extended PRN use. Although a handwritten note on the pharmacy report indicated a stop date was in place, the medical record did not contain the necessary documentation to support the extended use of Lorazepam as required by CMS guidelines.

An unhandled error has occurred. Reload 🗙